Home  >  News
Eppen_Himac_Jan25
Waters_Ebook_Dec24
you can get e-magazine links on WhatsApp. Click here
News
  Vaxxas and CEPI advance US$ 4.8 million programme for needle-free thermostable mRNA vaccines,   January 24, 2025
  Immuneel Therapeutics launches Qartemi, India’s first global CAR T-cell therapy for non-Hodgkin’s lymphoma,   January 20, 2025
  Illumina & NVIDIA collaborate to decode biology and propel precision health,   January 15, 2025
  Illumina launches pilot proteomics programme with UK Biobank and biopharma collaborators to analyze 50,000 samples,   January 14, 2025
  US FDA accepts for review GSK’s Shingrix new prefilled syringe presentation,   January 11, 2025
  TechInvention partners with Ethiopia's Ministry of Health to advance vaccine manufacturing in Africa,   January 10, 2025
  Sutro Biopharma & Boehringer Ingelheim BioXcellence collaboration: Established first-in-class cell-free capabilities at commercial scale,   January 09, 2025
  Qiagen supports UK initiative to sequence genomes of 100,000 newborns with expert-curated genomic content,   January 09, 2025
  WuXi Biologics grants exclusive global rights of trispecific t-cell engager to Candid Therapeutics,   January 08, 2025
  Biocon Biologics completes one-year as an integrated global biosimilars enterprise,   January 08, 2025
  eMBR Genomics partners with Axio BioPharma to make MKLP1 Pro antibodies commercially available,   January 07, 2025
  Exicure joins hands with GPCR Therapeutics for growth in biotech,   December 28, 2024
  Quantum-Si submits new paper to bioRxiv; demonstrates advances in protein variant detection using ProteoVue with next-generation protein sequencing,   December 26, 2024
  PeproMene Bio receives $11 million investment from IFLI to advance BAFF-R CAR T-cell therapy for relapsed/refractory follicular lymphoma,   December 23, 2024
  US FDA approves Mesoblast’s mesenchymal stromal cell therapy, Ryoncil for steroid-refractory aGvHD in children 2 months and older,   December 23, 2024
  Valneva signs exclusive license agreement with Serum Institute of India for its single-shot chikungunya vaccine to supply in Asia,   December 23, 2024
  Samsung invests in Generate to advance AI-driven protein therapeutics discovery,   December 21, 2024
  Polyrizon inks manufacturing agreement for its PL-14 allergy blocker with Eurofins CDMO Amatsiaquitaine,   December 21, 2024
  Novo Nordisk Foundation grants €134.1 mn to set up Biotechnology Research Institute for Green Transition in Denmark,   December 20, 2024
  Lilly and EVA Pharma receive Egyptian Drug Authority approval for insulin glargine injection and release of locally manufactured insulin in Egypt,   December 19, 2024

 Back
 
Asia_Lab_Expo2025
chemexpoindia
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram